The availability of highly active antiretroviral therapies (HAART) has not eliminated HIV-1
infection of the central nervous system (CNS) or the occurrence of HIV-associated …

HIV-1 replication in the central nervous system (CNS) is typically limited by the availability of
target cells. HIV-1 variants that are transmitted and dominate the early stages of infection …

Infection by the lentivirus, human immunodeficiency virus type 1 (HIV-1), results in a variety
of syndromes involving both the central (CNS) and the peripheral (PNS) nervous systems …

Primary cultures of human embryonic neurons and astrocytes have been used to test the
interactions between neural cells and either human immunodeficiency virus type 1 (HIV‐1) …

Significant contributions from many different groups during the last 2 or 3 years have
characterized relatively uniform neuropathological changes of the CNS in AIDS patients …

Objectives: The majority of HIV-1-infected individuals manifest a plethora of central nervous
system (CNS) diseases unrelated to opportunistic infections, including AIDS dementia …

One neuronal cell line (SK-N-MC) was found to be susceptible to productive infection by
multiple isolates of the human immunodeficiency virus type 1 (HIV-1). Characterization of SK …

Human immunodeficiency virus type 1 (HIV-1) primarily infects CD4+ T cells and cells of the
monocyte–macrophage lineage, resulting in immunodeficiency in an infected patient. Along …

HIV infection in brain revolves around productive viral replication in cells of mononuclear
phagocyte lineage, including brain macrophages, microglia, and multinucleated giant cells …

HIV associated neurocognitive disorders and their histopathological correlates largely
depend on the continuous seeding of the central nervous system with immune activated …